François Dreyfus

Medicine · Health Sciences

64h-index18.2kcitations232works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(151), Myeloproliferative Neoplasms: Diagnosis and Treatment(47), Multiple Myeloma Research and Treatments(44), Chronic Lymphocytic Leukemia Research(42), Hemoglobinopathies and Related Disorders(30)

Publications231 total

Supplementary Figure Legend, Table 1 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Data from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Supplementary Figures 1 - 4 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Supplementary Figure Legend, Table 1 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Supplementary Figures 1 - 4 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Data from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
2023Open Access
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
Leukemia·2020· 10 citedOpen Access
PF393 A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT‐LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)
HemaSphere·2019· 2 citedOpen Access
Issue Information
European Journal Of Haematology·2018Open Access
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion‐dependent patients with low‐risk <scp>MDS</scp> and iron overload
European Journal Of Haematology·2018· 9 cited
Dyserythropoiesis Evaluated by Red Score and Hepcidin/Ferritin Levels Predicts Response to Erythropoietin in Lower Risk Myelodysplastic Syndromes
SSRN Electronic Journal·2018Open Access
Which second line treatments after ESA failure?
Oncotarget·2017· 1 citedOpen Access
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
Blood Cancer Journal·2017· 10 citedOpen Access
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents
Journal of Clinical Oncology·2017· 97 citedOpen Access
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study.
HAL (Le Centre pour la Communication Scientifique Directe)·2017
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
Blood·2016· 51 citedOpen Access
Time-dependent changes in mortality and transformation risk in MDS
Blood·2016· 175 citedOpen Access
A randomized phase II trial of azacitidine +/- epoetin-  in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents
Haematologica·2016· 61 citedOpen Access
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
Haematologica·2016· 47 citedOpen Access
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis
British Journal of Haematology·2016· 18 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Pierre Fenaux(22), Norbert Vey(16), Michaëla Fontenay(15), Sophie Park(15), Didier Bouscary(14), Odile Beyne‐Rauzy(13), Olivier Kosmider(12), Lionel Adès(10), Patrick Mayeux(10), Norbert Ifrah(10), Catherine Lacombe(9), Olivier Bernard(9), Bruno Quesnel(9), Valérie Bardet(9), Nicolas Chapuis(9), Raphaël Itzykson(8), Claude Preudhomme(8), Aspasia Stamatoullas(8), Jérôme Tamburini(8), Véronique Gelsi‐Boyer(7)